Wednesday, October 28, 2026

GenomeWeb Makes PAMA’s Impact Personal—with a Downloadable Spreadsheet

›
  GenomeWeb Makes PAMA’s Impact Personal—with a Downloadable Spreadsheet The reporting: substantial cuts, and uncertain relief Chat GPT 6 (L...
Tuesday, October 27, 2026

PAMA Bizarre Patterns Revisited: When Outliers Drive Your Cash Flow

›
 A week ago, we used PAMA raw data to show not just the median price for codes, but the actual distribution of  payments (normal vs bimoda v...

Employers Sue United Healthcare: Does It Overpay Providers??

›
 Header:  A large group of employers sues United Healthcare, asserting it overpays providers when it is merely dolely out third-party admini...
Monday, October 26, 2026

A Mouse is Not a Microscope: Digital Pathology Waiting for Quantum Leap in User Devices

›
Header:   Should digital pathology have a true revolution in the quality of input devices? ### Recently, we blogged about how digital pathol...
Sunday, October 25, 2026

Version 2: CMS, NIH, FDA Websites Switching to "SUPER INTELLIGENCE"

›
VERSION TWO - SUPER INTELLIGENCE The original version of this blog discussed government websites switching to "SUPER INTELLIGENCE"...

Version One; It's Here, It's Now: CMS, NIH, FDA Websites Switching to "SUPER INTELLIGENCE"

›
This summary is not available. Please click here to view the post.
Saturday, October 24, 2026

PAMA Unveils Bizarre Patterns for US Lab Test Pricing

›
Here's an analysis run mostly by AI, based on my ability to "vibe code" instructions of what AI had to do with raw PAMA Excel ...

CMS New Voluntary Exclusion Authority: What Court Cases Have Said

›
This month, RFK Jr gave CMS itself the elective exclusion authority long reserved only for referral to the OIG's attorneys. Blog . Here ...

Dr. Oz Videos: (#1) Hates Lab Industry, (#2) Deep Dive on Fraud, Documentary

›
HEADER Dr. Oz’s recent and biting criticism of laboratory pricing and CMS’s unusual fraud documentary reveal an increasingly aggressive agen...
Thursday, October 22, 2026

Speeding Up Digital Pathology: Great Lessons from Adoption of Da Vinci Robotic Surgery

›
 We often hear that adoption of digital pathology (since, for example, the $100M acquisition of Bioimagene by Roche almost twenty years ago)...